Walleye Trading
TARA icon

Walleye Trading’s Protara Therapeutics TARA Stock Holding History

Walleye Trading’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-30
Closed -$11K – 5173
2016
Q3 		$11K Buy
+30
New +$10.6K ﹤0.01% 4389

Other funds holding TARA

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PI
Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
DVC
Deer VII & Co Larchmont, New York $317M AUM 30.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
FCI
Financial Counselors Inc Overland Park, Kansas $70.9M AUM 16.78% 1-Year Est. Return

Walleye Trading's TARA Position: Q4 2016 in Review

Walleye Trading sold out of Protara Therapeutics (TARA) in Q4 2016, closing a stake of 30 shares — an estimated $11K sold.

Walleye Trading first reported a position in TARA in Q3 2016 and held it in 1 quarter. The position peaked at $11K in Q3 2016. 25 funds tracked by Wall St. Rank hold TARA as of Q4 2016.

  • Walleye Trading reported no remaining Protara Therapeutics position as of Q4 2016 after selling out during the quarter.
  • Walleye Trading sold 30 Protara Therapeutics shares in Q4 2016, an estimated $11K.
  • Walleye Trading first reported a position in Protara Therapeutics in Q3 2016 and held it in 1 quarter.
  • Walleye Trading's Protara Therapeutics position peaked at $11K in Q3 2016.
  • 25 funds tracked by Wall St. Rank held Protara Therapeutics as of Q4 2016.

Based on Walleye Trading's 13F filing for Q4 2016, filed 14 Feb 2017.